Consultor Técnico De Doenças Raras – Campinas Ou Ribeirão Preto
AstraZeneca
Campinas, São Paulo, Brazil
On-site
Technical knowledge of rare diseases
Develop and execute strategic plans
Engage with healthcare professionals
AstraZeneca is seeking a Technical Consultant for Rare Diseases based in Campinas or Ribeirão Preto, Brazil. The role involves establishing relationships with healthcare professionals, implementing strategic plans for demand generation, and contributing to patient access to accurate diagnoses and treatments
Job Summary
The Technical Consultant in Rare Diseases acts in a defined territory, establishing consistent relationships with doctors and other health professionals, documenting all interactions and activities related to rare diseases for which our products are indicated.
Develop, implement, and review strategic plans per account, aligned with the territory dynamics and the objectives of the Rare Diseases BU, ensuring focus on demand generation and medical education.
The role requires a deep technical-scientific knowledge of rare diseases, diagnosis, and available therapies, sustaining robust clinical discussions with HCPs and other stakeholders.
Matching Summary
Match Score: 85
AstraZeneca is seeking a Technical Consultant for Rare Diseases based in Campinas or Ribeirão Preto, Brazil. The role involves establishing relationships with healthcare professionals, implementing strategic plans for demand generation, and contributing to patient access to accurate diagnoses and treatments.
Skills & Requirements
Must-have
Technical knowledge of rare diseases
Develop and execute strategic plans
Engage with healthcare professionals
Document interactions and activities
Travel regularly within territory
Nice-to-have
Contribute to a learning culture
Build trusting relationships
Propose and execute growth actions
Key Requirements
Graduation in Administration, Marketing, or Health Area
Experience as a sales consultant in rare diseases
Valid National Driver's License (CNH)
Availability to travel regularly (> 60% of the time)